We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer/BioNTech Finalize 300 Million-Dose EU Vaccine Supply Deal, But Face Questions on Distribution
Pfizer/BioNTech Finalize 300 Million-Dose EU Vaccine Supply Deal, But Face Questions on Distribution
Pfizer and BioNTech, current frontrunners in the race for an approved COVID-19 vaccine, have finalized an agreement with the European Commission to supply 300 million doses of their vaccine starting by year’s end — but the vaccine’s distribution is expected to face serious challenges worldwide because it must be stored at super-cold temperatures.